Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction
Abraham Bayer, Marìa Zambrano, Sasha Smolgovsky, Zachary L. Robbe, Abul Ariza Manzano, Kuljeet Kaur, Machlan Sawden, Anne C. Avery, Cheryl A. London, Aarti Asnani, Pilar Alcaide
Topics & Concepts
DoxorubicinCytotoxic T cellMedicineInternal medicineCardiac dysfunctionCardiologyCardiac fibrosisFibrosisChemotherapyBiologyHeart failureIn vitroBiochemistryChemotherapy-induced cardiotoxicity and mitigationCardiac Fibrosis and RemodelingCAR-T cell therapy research